CareCloud, Inc. (NASDAQ:CCLD) is a key player in the healthcare technology and generative AI solutions sector. The company recently reported its Q4 2024 earnings, revealing an earnings per share (EPS) of $0.20, slightly below the estimated $0.22. Despite this, CareCloud exceeded revenue expectations, generating $28.24 million compared to the estimated $25.90 million.
During the earnings call on March 13, 2025, CareCloud's leadership, including Co-CEOs Stephen Snyder and Hadi Chaudhry, discussed the company's financial performance. The call, attended by analysts from Zacks Small-Cap Research, Ladenburg Thalmann, and Maxim Group, highlighted CareCloud's strategic execution and AI-driven innovation. The company achieved a net income of $7.9 million for the full year ending December 31, 2024, a significant improvement from the previous year's net loss of $48.7 million.
CareCloud's financial metrics reflect its strong performance and strategic positioning. The company reported an adjusted EBITDA of $24.1 million, a 56% increase from 2023. Additionally, free cash flow surged by 244% to $13.2 million, underscoring the company's effective cash management. These results have allowed CareCloud to resume dividends and strengthen its balance sheet, setting the stage for continued profitability and growth.
The company's valuation metrics further emphasize its financial health. With a price-to-earnings (P/E) ratio of approximately 3.31 and a price-to-sales ratio of about 0.23, CareCloud is valued modestly by the market. The enterprise value to sales ratio of around 0.22 and an enterprise value to operating cash flow ratio of approximately 1.18 indicate strong cash flow generation relative to its enterprise value.
CareCloud's financial stability is also evident in its low debt-to-equity ratio of 0.07, reflecting a conservative approach to leveraging. The current ratio of 1.27 indicates a healthy level of liquidity, ensuring the company can cover its short-term liabilities. With an earnings yield of 30.21%, CareCloud offers a strong return on investment for its shareholders, highlighting its potential for long-term growth.
Symbol | Price | %chg |
---|---|---|
2413.T | 1656 | -1.96 |
IKS.NS | 1518.55 | 0 |
IKS.BO | 1517.95 | 0 |
SAGILITY.BO | 42.85 | 0 |